Navigating Travel in Europe During the Pandemic: from Mobile Apps, Certificates and Quarantine to Traffic-light System

Overview

Journal J Travel Med

Publisher Oxford University Press

Specialties Infectious Diseases
Public Health

Date 2022 Feb 8

PMID 35134215

Authors

Justine I Blanford

Nienke Beerlage-de Jong

Stephanie E Schouten

Alex W Friedrich

Vera Araujo-Soares

Affiliations

Soon will be listed here.

Abstract

Background: Ever since 2020, travelling has become complex, and increasingly so as the COVID-19 pandemic continues. To reopen Europe safely, a consensus of travel measures has been agreed between countries to enable movement between countries with as few restrictions as possible. However, communication of these travel measures and requirements for entry are not always clear and easily available. The aim of this study was to assess the availability, accessibility and harmonization of current travel information available in Europe.

Methods: We performed a systematic documental analysis of online publicly available information and synthesized travel entry requirements for all countries in the European Union and Schengen Area (N = 31). For each country we assessed entry requirements, actions after entry, how risk was assessed, and how accessible the information was.

Results: We found varying measures implemented across Europe for entry and a range of exemptions and restrictions, some of which were consistent between countries. Information was not always easy to find taking on average 10 clicks to locate. Twenty-one countries required pre-travel forms to be completed. Forty apps were in use, 11 serving as digital certification checkers. All countries required some form of COVID-19 certification for entry with some exemptions (e.g. children). Nineteen percent (n = 6) of countries used the ECDC risk assessment system; 80% (n = 25) defined their own. Forty-eight percent (n = 15) of countries used a traffic-light system with 2-5 risk classifications.

Conclusion: A comprehensive set of measures has been developed to enable continued safe travel in Europe. However further refinements and coordination is needed to align travel measures throughout the EU to minimize confusion and maximize adherence to requested measures. We recommend that, along with developing travel measures based on a common set of rules, a standard approach is taken to communicate what these measures are.

Citing Articles

Circular economy, environmental quality and tourism receipts in Europe: A time series data analysis.

Erdiaw-Kwasie M, Owusu-Ansah K, Abunyewah M, Alam K, Hailemariam A, Arhin P PLoS One. 2023; 18(11):e0288098.

PMID: 38032922 PMC: 10688725. DOI: 10.1371/journal.pone.0288098.

A comparative study of eight COVID-19 protective measures and their impact on Swiss tourists' travel intentions.

Husser A, Ohnmacht T Tour Manag. 2023; 97:104734.

PMID: 36712143 PMC: 9874056. DOI: 10.1016/j.tourman.2023.104734.

Non-pharmaceutical interventions in response to the COVID-19 pandemic in 30 European countries: the ECDC-JRC Response Measures Database.

Lionello L, Stranges D, Karki T, Wiltshire E, Proietti C, Annunziato A Euro Surveill. 2022; 27(41).

PMID: 36239171 PMC: 9562809. DOI: 10.2807/1560-7917.ES.2022.27.41.2101190.

References

Monti M, Torbica A, Mossialos E, Mckee M . A new strategy for health and sustainable development in the light of the COVID-19 pandemic. Lancet. 2021; 398(10305):1029-1031. PMC: 8445693. DOI: 10.1016/S0140-6736(21)01995-4. View

Errett N, Sauer L, Rutkow L . An integrative review of the limited evidence on international travel bans as an emerging infectious disease disaster control measure. J Emerg Manag. 2020; 18(1):7-14. DOI: 10.5055/jem.2020.0446. View

Araujo-Soares V, Hankonen N, Presseau J, Rodrigues A, Sniehotta F . Developing Behavior Change Interventions for Self-Management in Chronic Illness: An Integrative Overview. Eur Psychol. 2019; 24(1):7-25. PMC: 6727632. DOI: 10.1027/1016-9040/a000330. View

Blasimme A, Ferretti A, Vayena E . Digital Contact Tracing Against COVID-19 in Europe: Current Features and Ongoing Developments. Front Digit Health. 2021; 3:660823. PMC: 8521942. DOI: 10.3389/fdgth.2021.660823. View

Dehning J, Zierenberg J, Spitzner F, Wibral M, Neto J, Wilczek M . Inferring change points in the spread of COVID-19 reveals the effectiveness of interventions. Science. 2020; 369(6500). PMC: 7239331. DOI: 10.1126/science.abb9789. View

Pavli A, Maltezou H . COVID-19 vaccine passport for safe resumption of travel. J Travel Med. 2021; 28(4). PMC: 8247263. DOI: 10.1093/jtm/taab079. View

The Lancet Infectious Diseases . The COVID-19 infodemic. Lancet Infect Dis. 2020; 20(8):875. PMC: 7367666. DOI: 10.1016/S1473-3099(20)30565-X. View

Sharma T, Bashir M . Use of apps in the COVID-19 response and the loss of privacy protection. Nat Med. 2020; 26(8):1165-1167. DOI: 10.1038/s41591-020-0928-y. View

Lau H, Khosrawipour V, Kocbach P, Mikolajczyk A, Schubert J, Bania J . The positive impact of lockdown in Wuhan on containing the COVID-19 outbreak in China. J Travel Med. 2020; 27(3). PMC: 7184469. DOI: 10.1093/jtm/taaa037. View

10.

Dickens B, Koo J, Lim J, Sun H, Clapham H, Wilder-Smith A . Strategies at points of entry to reduce importation risk of COVID-19 cases and reopen travel. J Travel Med. 2020; 27(8). PMC: 7499710. DOI: 10.1093/jtm/taaa141. View

11.

Lytras T, Dellis G, Flountzi A, Hatzianastasiou S, Nikolopoulou G, Tsekou K . High prevalence of SARS-CoV-2 infection in repatriation flights to Greece from three European countries. J Travel Med. 2020; 27(3). PMC: 7184451. DOI: 10.1093/jtm/taaa054. View

12.

Johansson M, Wolford H, Paul P, Diaz P, Chen T, Brown C . Reducing travel-related SARS-CoV-2 transmission with layered mitigation measures: symptom monitoring, quarantine, and testing. BMC Med. 2021; 19(1):94. PMC: 8043777. DOI: 10.1186/s12916-021-01975-w. View

13.

Dickens B, Koo J, Lim J, Park M, Quaye S, Sun H . Modelling lockdown and exit strategies for COVID-19 in Singapore. Lancet Reg Health West Pac. 2021; 1:100004. PMC: 7395828. DOI: 10.1016/j.lanwpc.2020.100004. View

14.

Hurford A, Rahman P, Loredo-Osti J . Modelling the impact of travel restrictions on COVID-19 cases in Newfoundland and Labrador. R Soc Open Sci. 2021; 8(6):202266. PMC: 8206704. DOI: 10.1098/rsos.202266. View

15.

Carvalho T, Krammer F, Iwasaki A . The first 12 months of COVID-19: a timeline of immunological insights. Nat Rev Immunol. 2021; 21(4):245-256. PMC: 7958099. DOI: 10.1038/s41577-021-00522-1. View

16.

Chen L, Freedman D, Visser L . COVID-19 Immunity Passport to Ease Travel Restrictions?. J Travel Med. 2020; 27(5). PMC: 7313786. DOI: 10.1093/jtm/taaa085. View

17.

Drake J, Chew S, Ma S . Societal learning in epidemics: intervention effectiveness during the 2003 SARS outbreak in Singapore. PLoS One. 2006; 1:e20. PMC: 1762333. DOI: 10.1371/journal.pone.0000020. View

18.

Wells C, Pandey A, Fitzpatrick M, Crystal W, Singer B, Moghadas S . Quarantine and testing strategies to ameliorate transmission due to travel during the COVID-19 pandemic: a modelling study. Lancet Reg Health Eur. 2022; 14:100304. PMC: 8743228. DOI: 10.1016/j.lanepe.2021.100304. View

19.

Devi S . Travel restrictions hampering COVID-19 response. Lancet. 2020; 395(10233):1331-1332. PMC: 7180010. DOI: 10.1016/S0140-6736(20)30967-3. View

20.

Decaro N, Martella V, Saif L, Buonavoglia C . COVID-19 from veterinary medicine and one health perspectives: What animal coronaviruses have taught us. Res Vet Sci. 2020; 131:21-23. PMC: 7138383. DOI: 10.1016/j.rvsc.2020.04.009. View